Alimta

... Kiplinger.com - THREE DRUG STOCKS RIPE FOR RECOVERY SEARCH STOCK PRICE /tr> Find Stock Symbol About the Archive HOME PAGEToday’s columns, news and more BASICSBuild your financial know-how INVESTINGTips and tools for your portfolio YOUR FINANCESLatest rates and money-saving tips PLANNINGPut your financial goals into action SPENDINGResearch home, car and other purchases TOOLSCalculators for financial decisions COLUMNSAdvice and commentary from Kiplinger's experts COMMUNITYAsk a question or answer one EMAIL UPDATES Sign Up!

PUBLICATIONSSubscribe, renew, buy books and software CONTACT USCustomer service, feedback, letters to the editor ABOUT USCompany privacy and advertising info BOOST YOUR 401(K) New online course from Kiplinger helps you make the most of your savings.

See how...

Kiplinger Store: Give a Gift Subscription for Just $10 Investing: MARKET SNAPSHOT STOCKS FUNDS BONDS PORTFOLIO TRACKER RESEARCH EARNINGS CENTER STOCKS TO WATCH BUYING & SELLING STRATEGIES STOCK FINDER MAGAZINE February Magazine Contents Web Links Past Issues Try a Free Issue Customer Service Feedback GETTING STARTED Build a Strong Stock Portfolio Earnings: The Bottom Line Ten Clues to Strong Stocks Four Questions to Ask Before You Buy A Kid-Friendly Introduction to Stocks MORE...

STOCK TOOLS Kiplinger's Stock Finder Test your risk tolerance What is the current yield from dividends?

Which are better: income or growth stocks?

Pick the Best 'Bankerage' Company RE...

... Pharmaceutical Companies Rethink Consumer Marketing Strategies in 2005 Pharmaceutical Companies Rethink Consumer Marketing Strategies in 2005 New Study Finds Internet Provides a Promising Prescription for Change NEW YORK, Jan.

19 /PRNewswire-FirstCall/ - Facing increased scrutiny from the federal government and the public, pharmaceutical companies are looking beyond direct-to-consumer (DTC) marketing to more effectively communicate the benefits and risks of their products.

A new study from Manhattan Research, LLC (http://www.manhattanresearch.com), a healthcare marketing information and services firm, finds that over 45 million consumers (called ePharma Consumers in the study) are now using the Internet for drug information - providing a prime opportunity for pharmaceutical companies to leverage online venues for building relationships with consumers.

The study finds that most ePharma Consumers believe the Internet is a critical source of information about prescription drugs and that pharmaceutical product websites are a helpful resource for consumers.

They visit pharmaceutical information websites for a variety of reasons - for example, to learn about a drug's side effects and interactions, to learn about conditions treated by a drug, to read instructions for taking a drug, for clinical trials results, and to look for information to supplement a doctor's visit.

"In light of recent developments linking some high profile pharmaceutical products with the...

... FDA Approves Lung Cancer Drug